| Cell line |
Species |
Tissue |
Culture medium |
Cencentration |
|
AtT-20
|
mouse |
pituitary tumor |
Dulbecco's modified Eagle's medium |
700 (μg/ml)
|
|
B95-8
|
|
|
RPMI 1640 Medium |
0.4 (μg/ml)
|
|
A9
|
mouse/mouse |
hybridoma |
Dulbecco's modified Eagle's medium |
1600 (μg/ml)
|
|
293
|
human |
kidney; fetal |
Dulbecco's modified Eagle's medium |
700 (μg/ml)
|
|
Caco-2
|
human |
colon; colorectal adenocarcinoma |
|
700 (μg/ml)
|
|
MDCK (NBL-2)
|
dog |
kidney |
Minimal essential medium |
600 (μg/ml)
|
|
CHO-K1
|
hamster, Chinese |
ovary |
|
500 (μg/ml)
|
|
MDCK (NBL-2)
|
dog |
kidney |
Dulbecco's modified Eagle's medium |
700 (μg/ml)
|
|
A-431
|
human |
epidermis; epidermoid carcinoma |
Dulbecco's modified Eagle's medium |
1500 (μg/ml)
|
|
PT67
|
mouse |
embryo; amphotropic retroviral packaging line |
|
300 (μg/ml)
|
|
CHO-K1
|
hamster, Chinese |
ovary |
|
400 (μg/ml)
|
|
293T
|
human |
Kidney (embryonic) |
RPMI 1640 Medium |
800 (μg/ml)
|
|
HT-1080
|
human |
connective tissue; fibrosarcoma |
|
800 (μg/ml)
|
|
SK-MES-1
|
human |
pleural effusion (metastasis); squamous cell carcinoma (lung primary) |
DMEM + F12 medium |
800 (μg/ml)
|
|
C6
|
rat |
brain; glioma |
Ham’s F-12 nutrient mixture |
800 (μg/ml)
|
|
N2a
|
|
|
Minimal essential medium |
800 (μg/ml)
|
|
MCF7
|
human |
pleural effusion (metastasis); adenocarcinoma (mammary gland primary) |
Dulbecco's modified Eagle's medium |
600 (μg/ml)
|
|
HCT 116
|
human |
colon; colorectal carcinoma |
Dulbecco's modified Eagle's medium |
500 (μg/ml)
|
|
293T
|
human |
Kidney (embryonic) |
Dulbecco's modified Eagle's medium |
1000 (μg/ml)
|
|
Lec2
|
hamster, Chinese |
ovary; reduced transport of CMP-sialic acid into Golgi compartment |
α-modified minimal essential medium |
500 (μg/ml)
|
|
HeLa
|
human |
cervix; adenocarcinoma |
Dulbecco's modified Eagle's medium |
500 (μg/ml)
|
|
HeLa S3
|
human |
cervix; adenocarcinoma |
Dulbecco's modified Eagle's medium |
500 (μg/ml)
|
|
A549
|
human |
Lungcarcinoma |
Dulbecco's modified Eagle's medium |
500 (μg/ml)
|
|
B16GM
|
|
|
RPMI 1640 Medium |
400 (μg/ml)
|
|
K562
|
human |
lymphoblastoid |
Dulbecco's modified Eagle's medium |
1000 (μg/ml)
|
|
LA-N-1
|
|
|
Iscove's modified Dulbecco's medium |
200 (μg/ml)
|
|
HeLa S3
|
human |
cervix; adenocarcinoma |
Dulbecco's modified Eagle's medium |
500 (μg/ml)
|
